michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I agree that it's a dramatic data and pairs nicely with all the other safety benefits that we've shown over time. The study has not yet been published, so I have to be somewhat careful in not sharing too much detail, but we've seen all the data and the abstract of it, and it's been submitted for publication by the authors. But it showed a very dramatic difference between the rates of silent strokes in manual ablation versus in robotic ablation and it was a nicely designed study. Every patient had pre-op MRI, post-op MRI.
They looked for the differences between those two images to kind of discern the rate and severity of the silent strokes. And again, it was kind of very, very dramatic differences between the two arms in a relatively large number of patients. So I hope that it gets published in the near term, and we can point the investment community, too, and, obviously, more importantly, our customers and the physician community to that data, but we have to wait until it gets published.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. Well, I think what we said in the press release that we saw numerical improvements in very long-chain fatty acids and we had the P values for the other lipids, LDL triglycerides and apo B in the press release. But generally, we just saw the numerical improvements in the very long-chain fatty acids.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes, it's extremely broad. And there's -- and if you think of security, there's that commodity kind of security operations center. We've been doing that for many years. But security now is expanding throughout, and it's not just about threat detection. It's really about how you're going to remediate that, how you're going to remediate that in a positive way going forward. And so our teams, particularly in the government space are kind of leading the way. I'd say, our U.K. teams, our U.S. team, our German team are kind of leading the way. We do this in France. So with governments, which then is permeating our opportunities to drive that into the commercial world. So it's pretty comprehensive.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
And, Richard, just to clarify one thing and maybe I'm unnecessary to, but the average revenue per customer, ARPU, on the subscription side was up 10%. Revenue, obviously, ahead of that.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. Let me start with -- can you give us a sense of you think -- if you look at drop size, average drop size now that we're starting to cycle COVID, lines per customer, volume per line when you sort of look at the productivity of the business. So what are you seeing with regard to those? And is drop size up nicely from maybe where it was a year -- well, certainly a year ago, but pre-COVID?

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
We would like to raise the expense ramp for the first to the fourth quarter to be between $60 million and $80 million. That would be up from the $45 million to $55 million that we mentioned on the February call, and that's a result of additional savings that we've achieved in the first quarter and a little bit of a shift in timing of spending for strategic initiatives, primarily to the second half of the year. The slightly wider range also captures the uncertainty around the expectation for the resumption in travel and entertainment expenses as the year progresses.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Meaning what -- how much did they have on their balance sheet, if not...

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. So in large part, we don't have a significant number of citywide in our portfolio in general, which is not in those markets -- in those types of properties. But we have a few -- I guess, without divulging exactly who they are and what properties they're at, a few bellwether groups that we kind of look at within each segment. So we're obviously focused -- we look very carefully at the pharma business, which when it materializes is a very strong business for us, and we're watching that very closely because they often have the ability to make decisions to book short term.
But once they have, they can push business off even in normal times, depending on when they do product launches and things like that. So we've been very careful on that. We're looking at business where we have a large -- a relatively large number of international attendees. In general, in our internal forecast, we have watched much of that out, the hotels have watched much of that out because we know that international attendance is certainly not assured at this point.
So if that gets to particularly challenging points when we saw this in the early days of COVID as well, companies may cancel their meetings if they're not going to get the international attendees they want, and that goes for both corporate group, but that's particularly notable, I think, for larger association groups that draw internationally. I think those are two good examples of things we're keeping a careful eye.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey, good morning, everyone.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
We are generally thinking our single family volume will be, in total for the year, similar to maybe slightly lower than last year. The -- of course, that's subject to a lot of same comments on normalization, right? So I think maybe slightly lower, whether that's 5%, 10%, that could change easily in both directions. Commercial real estate, we're expecting a somewhat better year in Fannie Mae DUS business. But obviously, that's going to happen over the next three quarters, and it will probably be second half loaded.
In general, CRE originations, portfolio quality loans that we sell. Originations will be up. We may hold sales to similar levels of last year. We're not sure yet.
We're trying to grow the balance sheet. Well, that depends on prepayment speeds. And so we are still considering what amount of those loans we might sell. I think if you folks plan for sales similar to last year, that might be a good number.
We might exceed it or might be less, depending upon our experience with prepayments.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Understood. And then final question for me. The end markets are finally recovering, fortunately. And you're doing better as well from a margin standpoint as we've seen in the fourth quarter and your stock has recovered. I guess I'm curious as to how you're thinking about the balance sheet going forward. There's still, as we all know, quite a bit of debt there. What is your view on the strategy here as we think about the next two to three years, any updated thoughts from the board? Curious to know.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. So on the acquisition front, I mean we -- for Q1, the revenue was less than $10 million in aggregate, in line with our expectations for the quarter. So we're off to a strong start, but Q1 was less than $10 million. So relatively immaterial, and most of that would have showed up in Enterprise, given the customers, accelerated products predominantly being cloud-ready data center and AI-driven Enterprise oriented revenue products. We're still on track for the full-year to get to a 1% in aggregate growth across $45 million, give or take for the year, from revenue perspective, and we do think these acquisitions as we said before will be dilutive in FY'21 by about $0.05, and that's something that we expect to pressure in the second half and actually be accretive here in 2022. So while they are a bit of a drag on overall earnings this year, we expect them to enable us to expand margins in 2022 and beyond.
Second part of your question, I'm sorry, one was about the acquisitions. What was the second part of your question?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sorry, Ed, were you going to say something?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So --

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Dave Heikkinen will be pronounceable but thanks for taking my question. As you talked about the moves in Washington, D.C., can you just refresh us on your thinking about cash taxes? And then really, thinking about D.C. moves, and how that would fit in or factor into your long-term return of cash to shareholders thinking because it seems like a variable that we're going to have to address?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Perfect.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi, guys. Thanks for taking the question. One in clarification, on manufacturing compensability in the CMC, I was under the impression that you would have to generate actual commercial products and dose patients with it in order to get that CMC compatibility. Is that true? And if so, what would we hear about those patients and when? That's one.
Second, I'd love to hear your updated thoughts on potential partnerships for only ex-U.S. I think you had been talking about doing that. Do you have preferred timing for when we could expect a deal like that and what are you looking for in a potential partner ex-U.S.?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you, Paul.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure, Travis. Yes, I appreciate the question. I think it may be helpful to take a step back to where we were in May. We had received the agencies' feedback on our submission, and there were no surprises, which had put us on track for our anticipated timeline. We are very fortunate to be a part of the breakthrough devices program, and that allows us frequent collaboration with the agency. So we took the opportunity to discuss in more detail full mobile phone control and get extreme clarity on the FDA's response. Their feedback was really helpful for us and valuable and it prompted us to update our app with a feature that we believe will improve the customer experience. So that is basically what's happened since May. And the work is well underway, including all of our verification and validation testing. And then our assessment of that final work and the FDA's review and then, of course, some buffer because times are not normal given the COVID work load, that all puts us toward a Q4, we believe, late in Q4 clearance and limited market release. So that's kind of where we are. I would just emphasize that in the meantime, we are not standing still, the teams are doing great work preparing for a limited market release and I think making really good use of the time that we have while we get to final clearance.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. It's around USD one a ton.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I think your conclusion was correct.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
It's about -- yes, Lieve?

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Jerry, let me answer your question. I assume what you mean this year is for 2021.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey good morning everyone. For better or for worse, probably the most popular investor question of late has been about maybe some of the negative headlines related to the COVID measurement issues. So maybe, David, could you expand on that just a little more? We've had the VAB call to remove MRC accreditation. What do you think the likelihood of that is? What would be the potential financial impact of a worst-case scenario? Because it does sound like the idea is acknowledging that everyone would continue to use the ratings. So just maybe a little bit more color on that would be helpful. And then maybe on the brighter side, you mentioned both Netflix and Google highlighting your streaming data on their earnings calls and then Google in particular highlighting it for YouTube more. How impactful is that to your business? Does your sales team start to feel that? Because it feels like that's an element that isn't being recognized as much as the secular leaders promoting your products for you these days. I'd love to hear more on that as well.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks. Good morning, Mike and Mike. Mike, I -- Mike Ragen, I wondered if you are able to quantify the second quarter impact from the resin mismatch.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi, thank you. This is David Karnovsky on for Alexia. I know it's an odd year for political, but you do have some governors races and the California recall. Any commentary you can provide on how this is shaping up versus 2017? And do you expect any midterm spend there? Is it just too early for that?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you. We look forward to seeing you then.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
We already have seen interest from customers on both sides and I think the ability to put the package together to expand where we go out with this both in what I'm saying is a complete package will be very interesting. I think, it will take some time to ramp that up. But we're already starting to get the organizations aligned to do that and having the conversations with a lot of the customers on both sides. So I think it'd be exciting and compelling and a complete package gives us much more latitude and options and ways to put it to a complete package to customers.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, as you know, we have limited business in Asia. And yes, we see some inflation due to some ancillary raw materials that we need to buy, mainly for our foundry business that we buy from Asia. This is the main inflationary costs that we see. So I refer this to this move and to magnesium purchase, but it is not something really massive at this stage or really significant.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi, good morning everyone. My first question is with regards to pricing. Commodity costs are increasing. You also have additional costs related to logistics and supply chain inefficiencies. So I was wondering, have you taken price increases this year to offset these additional costs?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, at least for the term ending in March 2021, had it not been for the incident, I believe that that level of number would have been achieved. Overall, we believe that our earnings capabilities are strengthened. And in that respect, we have confidence -- we are confident, but unfortunately we are starting from the negative JPY62 billion in the beginning of this fiscal year and we have to start from this negative level to generate profit. Structural reforms were under way to alleviate market impact, but we cannot be completely free from market impact. And so I believe we were enjoying some tailwind from market environment in 2020. I hope this addresses your question.

    Prediction (one of UP, DOWN, SAME): SAME